Karuna Therapeutics, Inc

KRTXStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$330.01

Today

+0.0%

YTD

+0.2%

About

Karuna Therapeutics Inc is an American clinical-stage biopharmaceutical company, developing and delivering therapies for patients with serious neuropsychiatric disorders. Founded in 2009, the company is headquartered in Boston, Massachusetts and is listed on the NASDAQ GM using the ticker KRTX. Add this stock to your watchlist and diversify your eToro portfolio.

Price chart

Closing price history for KRTX (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-28.13

P/S (TTM)19053.99

P/B (TTM)10.01

Market cap$12.60B

Cap tierLarge-cap

Industry avg P/E-7.26

Profitability

Gross margin-160.09%

EBIT margin-75653.98%

Net margin-14919.57%

ROE-36.44%

ROA-34.68%

Earnings & Revenue

Revenue (TTM)$654,000.00

Revenue growth (1Y)-93.9%

EPS (TTM)-$11.73

Free cash flow$-388.74M

Total debt$16.69M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.09

Employees339

Next earnings2 May '24

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.